| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $57.1M | +17.4% |
| SG&A Expense | $21.1M | +11.3% |
| Operating Income | -$78.2M | -15.7% |
| Net Income | -$66.9M | -5.6% |
| EPS (Basic) | -$1.19 | -4.4% |
| EPS (Diluted) | -$1.19 | -4.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.2M | -20.0% |
| Short-term Investments | $260.6M | -14.2% |
| Current Assets | $284.6M | -15.1% |
| Total Assets | $289.6M | -15.1% |
| Current Liabilities | $9.6M | -10.7% |
| Total Liabilities | $12.0M | -13.5% |
| Stockholders' Equity | $277.7M | -15.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.6M | -14.1% |
| Capital Expenditures | $256K | -72.1% |
| Investing Cash Flow | $52.5M | +123.8% |
| Financing Cash Flow | $724K | +208.1% |
| Free Cash Flow | -$58.8M | -12.6% |